South Africa’s HIV Injection Revolution | Johannesburg News

South Africa’s new HIV prevention shot, Lenacapavir (LEN), is revolutionizing HIV protection—with near-perfect efficacy and just two clinic visits per year. Already administered to nearly 55,000 people since June, LEN is especially vital for high-risk groups like young women, sex workers, transgender women, and men who have sex with men. Coming soon: cheaper generic versions by 2027, expanded clinic access, and a dual-option system with free daily pills. While the first visit requires two shots plus a few days of pills, follow-up visits within 24–28 weeks eliminate the need for pills. Many are switching to LEN for its convenience, freedom from daily reminders, and peace of mind—especially for those who travel or work in high-risk environments. This could be a major step toward ending AIDS as a public health threat. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b2d399ae467c2d96